You can get in touch with Jesus by emailing j.mosquera@newsweek.com A surge of responses flooded social media after Transportation Secretary Sean Duffy asked travelers how to make flying easier ...

Novo Nordisk and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market. South Africa's Competition Commission said ...

Smart insulin pens are rapidly gaining adoption due to their ability to automate insulin dose calculations, provide reminders, and integrate with glucose monitoring devices. As healthcare systems ...

The development of AI-powered smart insulin pens with machine learning algorithms is transforming diabetes management. Features such as automated dose reminders, real-time glucose monitoring ...

Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. The Danish drugmaker ...

LONDON, Nov 14 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing ...

This call – based on data published by MSF in the Journal of the American Medical Association (JAMA) Network Open, estimating that insulin pens could cost as little as $0.94 (R16,81) per pen ...

In a recent study published in Nature, researchers report the design and experimental efficacies of NNC2215, a novel insulin conjugate comprising synthetically added glucose-binding macrocycles ...

Incorporating insulin into ... another reason the pen can’t be used. Some, but not all, insulin injections are dependent on when you eat. Eating increases the amount of glucose in your ...

Over the past few years, there has been a notable shift towards the use of insulin pens in the public sector ... including prolonged duration of action, more stable glucose control with less ...

The shortage highlights a widening gulf in the standard of care for people with diabetes, most of whom live in low-income countries. By Stephanie Nolen Stephanie Nolen reports on global health ...

While both conditions are characterised by high blood glucose levels ... Painful insulin injections can also be made easier through sleek, smart insulin pen devices with finer needles.